IMVT
Immunovant Inc
32.00$
-0.2%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | |
| – | – | – | – | – | +483.3% | – | – | – | – | – | – | +24.5% | +1.7% | +2.6% | +0.3% | +2.9% | +1.2% | +1.8% | +2.4% | +0.6% | +1.7% | -83.4% | +10.3% | +25.0% | +11.3% | +11.2% | -19.2% | +33.7% | -1.9% | -3.8% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -105.6% | – | – | – | -233.8% | – | – | – | – | – | |
| – | +32.5% | +33.7% | +3.7% | +131.8% | -44.1% | -52.1% | +186.0% | +19.4% | -29.2% | +76.1% | -11.7% | +0.5% | +14.2% | +39.3% | +7.5% | -11.1% | +32.7% | +12.0% | +22.7% | -2.4% | -5.2% | +0.8% | +36.7% | +14.3% | +28.9% | -2.8% | -0.9% | +8.1% | +12.9% | -13.4% | +43.8% | +0.2% | – | |
| – | +1,393.6% | +142.6% | -19.8% | +64.6% | +162.6% | +46.2% | +3.7% | +53.0% | -6.9% | +17.2% | -2.3% | +8.5% | +45.7% | -29.3% | +32.4% | -21.6% | -0.6% | -0.8% | +5.5% | +24.0% | -10.1% | -4.5% | +12.2% | +26.9% | -1.8% | +7.1% | +2.0% | +29.0% | -32.7% | -11.8% | +11.8% | +2.5% | – | |
| – | +45.3% | +39.3% | -100.0% | +20,420.4% | +354.6% | +2,530.3% | +85.5% | +29.8% | -21.1% | +50.9% | -8.6% | +3.4% | +26.0% | +9.6% | +14.4% | -14.5% | +22.9% | +8.9% | +18.9% | +2.7% | -6.3% | -0.4% | +31.4% | +16.6% | +22.8% | -1.2% | -0.4% | +11.8% | +3.6% | -13.2% | +39.5% | +0.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | – | – | +0.0% | +50.8% | -33.8% | – | – | – | – | – | – | – | – | +326.5% | +226.0% | +155.1% | +27.2% | +8.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +5.7% | -4,350.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +91.5% | -3.2% | +800.1% | +108.1% | -27.7% | -159.0% | – | -16.7% | -1,017.5% | – | – | – | – | – | – | -25.9% | +48.3% | -356.1% | – | – | -123.8% | – | -66.8% | +1.3% | +94.9% | +283.6% | +56.6% | -34.9% | +161.3% | -283.2% | – | – | |
| – | – | – | – | – | -31.6% | -9,130.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.